Fundraising Fox

Longevity Investors & VC Firms in Europe

54 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.

OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
126 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
72 people
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
89 people
Illumina Ventures
Foster CityPre-Seed–Late Stage
40 people
LIFTT
TorinoPre-Seed–Late Stage
35 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
42 people
Advent Life Sciences
LondonSeed–Late Stage
29 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
EQT Life Sciences
LuxembourgSeed–Late Stage$11M – $66M
39 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
DOMiNO Ventures
AmsterdamSeed–Series B$220K – $1.1M
30 people
HealthCap
StockholmSeed–Growth
30 people
AdBio partners
ParisPre-Seed–Series A
21 people
Hiro Capital
LondonSeries A–Late Stage
24 people
Apollo Health Ventures
BerlinSeed–Series A
32 people
Exceptional Ventures
LondonPre-Seed–Series A
19 people
Hadean Ventures
OsloSeed–Growth
21 people
Flagship Pioneering
CambridgeSeed–Series A$500K – $10M
9 people
O2h Ventures
CambridgePre-Seed–Series A
23 people
Sciety
StockholmSeed–Growth
21 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
Maximon
ZugPre-Seed–Series A$11M
23 people
Kinled Holding
Hong KongSeed–Series A
1 person

Related lists

Data sourced from public filings and firms' own websites — see our methodology.